SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 3.580+12.2%3:36 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: coyote who wrote (2513)1/3/2000 4:58:00 PM
From: SteveR  Read Replies (1) of 2539
 
From this Sundays (1/2/00) Wall Street Journal. An excerpt of an article by Steven Swartz regarding a portfolio of 10 stocks for the next decade:

"Finally, our most controversial pick. Monsanto recently announced plans to merge with Pharmacia & Upjohn. Wall Street doesn't like the deal because it doesn't offer Monsanto shareholders a premium. And, admittedly, Monsanto management hasn't executed its vision of moving from a stodgy chemical and agriculture company into a futuristic biotechnology giant. Nonetheless, we think biotechnology has a very bright future, and that over time, investors will be rewarded by advances in such areas as cancer treatment and genetically engineered food."

Finally some good news (views?) on MTC.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext